Zeltiq Aesthetics Inc. (ZLTQ) Shares Up 3.3%
Shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) shot up 3.3% during mid-day trading on Wednesday . The company traded as high as $32.54 and last traded at $32.45, with a volume of 208,968 shares trading hands. The stock had previously closed at $31.42.
ZLTQ has been the subject of a number of analyst reports. Zacks Investment Research cut Zeltiq Aesthetics from a “hold” rating to a “sell” rating in a research report on Thursday, July 14th. Leerink Swann reaffirmed an “outperform” rating and issued a $43.00 price target on shares of Zeltiq Aesthetics in a research report on Wednesday, July 13th. Brean Capital reaffirmed a “buy” rating and issued a $35.00 price target on shares of Zeltiq Aesthetics in a research report on Tuesday, June 21st. TheStreet cut Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a research report on Friday, June 10th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and issued a $38.00 price target on shares of Zeltiq Aesthetics in a research report on Friday, May 13th. One research analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $36.63.
The firm has a market cap of $1.28 billion and a price-to-earnings ratio of 38.97. The company has a 50-day moving average price of $28.65 and a 200-day moving average price of $26.26.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last announced its quarterly earnings data on Tuesday, May 10th. The company reported ($0.25) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.25). The firm earned $64.50 million during the quarter, compared to the consensus estimate of $61.80 million. The business’s revenue was up 25.0% compared to the same quarter last year. During the same period last year, the business earned ($0.06) earnings per share. Equities research analysts predict that Zeltiq Aesthetics Inc. will post $0.01 EPS for the current fiscal year.
In related news, CEO Mark J. Foley sold 10,000 shares of Zeltiq Aesthetics stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $31.21, for a total value of $312,100.00. Following the transaction, the chief executive officer now directly owns 325,940 shares of the company’s stock, valued at $10,172,587.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Keith J. Sullivan sold 8,000 shares of Zeltiq Aesthetics stock in a transaction that occurred on Monday, July 11th. The shares were sold at an average price of $30.02, for a total transaction of $240,160.00. Following the completion of the transaction, the insider now directly owns 77,922 shares in the company, valued at $2,339,218.44. The disclosure for this sale can be found here.
Other hedge funds and institutional investors have recently made changes to their positions in the company. Wells Fargo & Company MN boosted its position in shares of Zeltiq Aesthetics by 765.2% in the fourth quarter. Wells Fargo & Company MN now owns 404,376 shares of the company’s stock worth $11,537,000 after buying an additional 357,636 shares during the period. Russell Frank Co boosted its position in shares of Zeltiq Aesthetics by 98.0% in the fourth quarter. Russell Frank Co now owns 211,197 shares of the company’s stock worth $6,044,000 after buying an additional 104,550 shares during the period. State of Tennessee Treasury Department purchased a new position in shares of Zeltiq Aesthetics during the fourth quarter worth about $2,853,000. Trexquant Investment LP purchased a new position in shares of Zeltiq Aesthetics during the fourth quarter worth about $1,640,000. Finally, New York State Common Retirement Fund boosted its position in shares of Zeltiq Aesthetics by 4.3% in the fourth quarter. New York State Common Retirement Fund now owns 41,532 shares of the company’s stock worth $1,185,000 after buying an additional 1,700 shares during the period.
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.